The depression in the shareprice will soon give way. Traditionally shares in Pahse 3 trials will continue to a usual 300% increase at least during this period. Its worth buying over this year in the lead up to readout, exciting times, this company should be double this shareprice by now, but will certainly be by the end of year and once the 2nd Phase 3 trial is fully enrolled in the next month OPT will gain the attention of the market and they will be off to the races. All the best holders
The depression in the shareprice will soon give way....
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $376.5M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.0¢ | 33.5¢ | $986.8K | 2.875M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55705 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 29727 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |